US8142491B2 - Stent segments axially connected by thin film - Google Patents
Stent segments axially connected by thin film Download PDFInfo
- Publication number
- US8142491B2 US8142491B2 US12/608,023 US60802309A US8142491B2 US 8142491 B2 US8142491 B2 US 8142491B2 US 60802309 A US60802309 A US 60802309A US 8142491 B2 US8142491 B2 US 8142491B2
- Authority
- US
- United States
- Prior art keywords
- thin film
- stent
- hoops
- film tube
- fabricating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000010409 thin film Substances 0.000 title claims abstract description 150
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000003780 insertion Methods 0.000 claims abstract description 7
- 230000037431 insertion Effects 0.000 claims abstract description 7
- 239000000853 adhesive Substances 0.000 claims description 11
- 230000001070 adhesive effect Effects 0.000 claims description 11
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000000151 deposition Methods 0.000 claims description 6
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 35
- 229910001000 nickel titanium Inorganic materials 0.000 description 33
- 239000000463 material Substances 0.000 description 30
- 229910000734 martensite Inorganic materials 0.000 description 26
- 230000008569 process Effects 0.000 description 18
- 229910045601 alloy Inorganic materials 0.000 description 16
- 239000000956 alloy Substances 0.000 description 16
- 239000010410 layer Substances 0.000 description 16
- 229910001566 austenite Inorganic materials 0.000 description 13
- 230000007704 transition Effects 0.000 description 11
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 238000003466 welding Methods 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 239000010935 stainless steel Substances 0.000 description 6
- 229910001220 stainless steel Inorganic materials 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 229920002120 photoresistant polymer Polymers 0.000 description 4
- 238000005498 polishing Methods 0.000 description 4
- 238000005019 vapor deposition process Methods 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 3
- 238000005219 brazing Methods 0.000 description 3
- 238000002788 crimping Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000005137 deposition process Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229910001092 metal group alloy Inorganic materials 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 229910000679 solder Inorganic materials 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000010952 cobalt-chrome Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013047 polymeric layer Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920006099 Vestamid® Polymers 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000009760 electrical discharge machining Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- RZDQHXVLPYMFLM-UHFFFAOYSA-N gold tantalum Chemical compound [Ta].[Ta].[Ta].[Au] RZDQHXVLPYMFLM-UHFFFAOYSA-N 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/4998—Combined manufacture including applying or shaping of fluent material
- Y10T29/49982—Coating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49995—Shaping one-piece blank by removing material
Definitions
- the present invention relates to an expandable intraluminal grafts (“stents”) for use within a body passageway or duct which are particularly useful for repairing blood vessels that have been narrowed or occluded by disease.
- stents which are self-expanding and made from a super elastic material such as Nitinol.
- Percutaneous transluminal coronary angioplasty is a therapeutic medical procedure used to increase blood flow through the coronary artery and can often be used as an alternative to coronary by-pass surgery.
- the angioplasty balloon is inflated within the stenosed vessel in order to disrupt the wall components of the vessel to obtain an enlarged lumen.
- the relatively incompressible plaque remains unaltered, while the more elastic medial and adventitial layers of the body passageway stretch around the plaque.
- Self-expanding stents that are radially and axially flexible have been developed that are composed of a plurality of flexible elements that form a self-expanding helix. These stents are implanted to open or dilate tubular structures and have been used for damaged blood vessels, biliary ducts, and other similar organs. The stents are an improvement over PTCA procedures because the implanted stent holds the intimal flap and plaque against the inner wall of the vessel preventing it from blocking the vessel.
- Prior art stents have some functional limitations due to their current design. For example, the prior art stent can collapse when it is bent around a sharp angle. What is needed is an improved stent that is more flexible and can be implanted in tightly bent vessels.
- the present invention is an improved stent has good radial strength to hold the vessel open and greater flexibility that is suitable for implantation in more sharply bent vessels.
- the inventive stent includes a thin film tube that is attached to a plurality of hoops axially aligned between the front and back ends of the stent.
- Each of the hoops includes a plurality of longitudinal struts and a plurality of loops connecting adjacent struts.
- the struts and loops form a continuous serpentine pattern around the diameter of the hoop.
- the thin film tube holds the hoops together and also provide a space between the adjacent hoops.
- the stent has a compressed diameter for simplified implantation into the patient and an expanded diameter that is assumed after it is inserted into the patient.
- the inventive stent is a tubular member that has front and back open ends and a longitudinal axis extending therebetween.
- the inventive stent has improved flexibility because the adjacent hoops are held together with a flexible thin film tube rather than bridges.
- the thin film tube is more flexible than the bridges because the thin film tube is much thinner.
- the thin film spans the area between the adjacent hoops and can easily fold when compressed. This improved flexibility allows the stent to be easily moved through blood vessels and deployed in a bent vessel within the patient.
- the more rigid bridges that couple the adjacent hoops restrict the bending radius of the prior art stents.
- the inventive stent has a first smaller diameter for insertion into the vessel and a second larger diameter for deployment into the vessel.
- the hoops of the stent include struts and loops that are bendable so that the hoops can be compressed to the smaller diameter.
- the loops are bent so that the adjacent struts are substantially parallel to the longitudinal axis of the stent and placed in very close proximity with only a small gap between them.
- the thin film tube is attached to the hoops and portions of the thin film tube may be folded between the gaps between the struts and loops when the stent are compressed to the smaller diameter.
- the hoops expand thereby forming larger gaps between the struts and loops.
- the thin film tube expands with the hoops to cover the gaps formed between the struts and loops.
- the thin film tube also traps plaque and other deposits between the stent and the vessel wall.
- prior art stents have gaps between the loops, struts and bridges that may not trap small pieces of plaque and debris.
- the thin film tube and hoops are made of a super elastic metal alloy that can change from the martensitic molecular phase to the austenitic phase by changing the stent temperature.
- the stent is compressed and loaded onto a delivery tube apparatus.
- the delivery device holds the stent in the compressed state and is used to transport the stent to a specific area within a patient.
- the stent is deployed at a damaged area of the blood vessel by releasing the stent from the delivery apparatus.
- the delivery device pushes the stent out of the delivery tube while simultaneously pulling the delivery tube back to expose the stent. This allows the inventive stent to expand radially to the inner diameter of the blood vessel without any axial movement relative to the vessel.
- the expanded stent remains axially stationary relative to the blood vessel to avoid damage during the deployment process.
- the stent may have radio opaque markers which allow the surgeons to monitor the location for the stent during the delivery procedure. By watching the position of the stent within the patient, the stent can be positioned within the vessel more accurately.
- the radio opaque markers can be attached to the stent by welding the markers to the stent. Alternatively, the markers may be attached with adhesives, mechanical fasteners or other coupling systems.
- inventive stent can be partially deployed and then retracted if it is improperly positioned within a patient. The stent can then moved to the proper location and redeployed. The inventive stent is retracted by pulling the stent back into the delivery tube which causes the stent to be recompressed within the delivery tube so that it can be moved the proper position and redeployed.
- the retraction capability may require longer stents so any positioning error can be detected before the stent is fully deployed and irretrievable.
- the delivery device is able to cut the inventive stent around the thin film tube between any adjacent hoops.
- the location of a partially deployed stent is monitored and if the position is correct, the portion of the stent in the delivery device is cut and the partially deployed section of the stent remains in the vessel. If the stent is improperly positioned, it can be retracted and repositioned as described above.
- the inventive stent is described as being made from a super elastic alloy, in an embodiment, the stent can also be made from more traditional stent materials that are not self expanding, such as stainless steel, cobalt-chromium, etc.
- an expansion mechanism is required to expand the stent after it is placed in the patient.
- the balloon is in the inner of the stent during the implantation process. Markers may be attached to the stent so the location can be determined before the stent is expanded.
- a tube extends from the balloon to a pump that inflates the balloon and expands the stent. The balloon and delivery apparatus are removed from the patient after the stent is implanted.
- FIG. 1 is a flat view of a portion of a hoop in the compressed state.
- FIG. 2 is a flat view of a portion of a hoop in the expanded state.
- FIG. 3 is a view of an embodiment of the stent with external hoops.
- FIG. 4 is a view of an embodiment of the stent with internal hoops.
- FIG. 5 is a view of an embodiment of the stent with external and internal hoops.
- FIG. 6 is an enlarged sectional view of the stent in the expanded state.
- FIG. 7 is an enlarged sectional view of the stent in the expanded state.
- FIG. 8 is a side view of the thin film tube.
- FIG. 9 is a side view of the stent partially deployed in a vessel.
- FIG. 10 is a simplified cross-sectional view of the stent delivery apparatus.
- FIG. 11 is an enlarged cross-sectional view of the distal end of the delivery apparatus.
- FIG. 12 is a stress strain curve for super elastic alloys such as Nitinol.
- the inventive stent includes a plurality of hoops and a thin film tube which are made of a super elastic metal alloy or more traditional materials such as stainless steel, cobalt-chromium, etc.
- a super elastic metal alloy is described as Nitinol, any alloy with similar super elastic properties may be used.
- the hoops of the inventive stent are made from Nitinol tube stock which is commercially available from a number of suppliers including Nitinol Devices and Components, Fremont Calif.
- the Nitinol tube used to form the hoops may be fabricated through a vapor deposition process.
- the thin film tube is preferably made through a deposition process, but may also be made from very thin tube stock.
- Vapor deposition refers to any process of depositing metals and metal compounds from a source to a substrate or target by dissipating metal ions from the source in a vaporous medium.
- the vapor deposition process builds a layer of Nitinol by depositing molecules of the alloy onto a cylindrical mandrel in a vacuum chamber.
- Examples of vapor deposition processes that may be used to make the present invention include evaporation vapor deposition, sputtering deposition, chemical vapor deposition, etc.
- vapor is generated by heating a source material to a temperature to cause the vaporization thereof.
- the evaporating metal atom leaves the surface of the Nitinol source material in a straight line. Therefore, the highest quality deposition layers are deposited when the source-to-substrate distance is less than the mean path distance between collisions of the vaporized metal and the surrounding vacuum chamber.
- the substrate may be rotated or translated during the evaporation process so that a uniform Nitinol layer is deposited on the substrate.
- a source material is placed in a vacuum chamber with a substrate material.
- a radio-frequency power source gives the substrate has a positive charge relative to the Nitinol source material.
- the source material is bombarded with inert gas ions from an ion beam or a plasma discharge to cause the source material to dislodge. These dislodged atoms are then deposited onto the substrate to form the thin film layer.
- the hoops In the chemical vapor deposition process, reactant gases that may be diluted in a carrier gas are injected into a reaction chamber. The gas mixture is heated and the atoms are deposited on a mandrel.
- the thickness of the hoops may range from about 0.005 to about 0.1 inch.
- the thickness of the thin film tube is less than the thickness of the hoops and may range from about 0.0001 to about 0.05 inch. Although the hoops and thin film tube may vary in thickness, the hoops are generally much thicker than the thin film tube.
- the deposition continues until the desired thickness is formed. The Nitinol tube is removed from the mandrel before being machined.
- the hoops 52 have a first small diameter for insertion into a vessel and a second larger diameter for deployment into the vessel.
- like numerals indicate the same element throughout the views.
- FIG. 1 a sectional view of a hoop 52 in the compressed state is illustrated.
- the hoops 52 each include a plurality of longitudinal struts 60 and a plurality of loops 62 that connect the adjacent struts 60 .
- the adjacent struts 60 are connected with loops 62 in an alternating pattern at opposite ends of the struts 62 , forming a serpentine or “S” shaped pattern.
- the loops 62 are substantially semi-circular and creates very sharp bend.
- the angle between the struts 60 may only be about 0° to 5°.
- the space between the struts 60 is small because the 180° bends of the loops 62 cause the struts 60 to be compressed close to each other.
- a sectional view of a hoop 52 in the expanded state is illustrated.
- the expansion of the hoop 52 may only be in the circumference and not the width.
- the angle ⁇ between adjacent struts 60 connected by the loops 62 increases from a compressed angle of about 0° to 5° to an expanded angle of about 30° to 70°.
- the expanded angle ⁇ of the loops 62 causes the struts 60 to separate and cause the hoop 52 to expand in circumference and diameter.
- the width of the hoop 52 gets narrower because the struts 60 are angled across the width rather than running perpendicular across the widths.
- the geometry of the struts improves the distribution of strain throughout the hoops.
- the number of struts and loops as well as the design of these components are important factors when determining the working properties and fatigue life of the stent.
- Hoops that have a large quantity of smaller sized struts have greater radial rigidity than hoops made with fewer larger struts.
- a stent where the ratio of the number of struts per hoop to the strut length L (in inches) that is greater than 400 has increased rigidity.
- the stent hoops can be fabricated in various different ways.
- the Nitinol tube is loaded into a machine that cuts the predetermined pattern of the expanded hoop.
- Machines that can cut sheets of Nitinol are well known to those of ordinary skill in the art and are commercially available.
- the tube is typically held stationary while a cutting tool, preferably under microprocessor control, moves over the sheet and cuts the desired hoop pattern.
- the pattern dimensions and styles, laser positioning requirements, and other information are programmed into a microprocessor which controls all aspects of the process.
- the cutting tool can be a laser, laser chemical etch, water jet, electrical discharge machining, etc.
- a photochemical etch process may be used to cut the desired hoop pattern into the Nitinol tube.
- This process can include various process steps that are generally known as photolithography.
- a photoresist layer is deposited onto the Nitinol tube and exposing the photosensitive layer to a pattern of light that matches the desired pattern that the hoop is to be cut into.
- the light chemically alters the exposed areas of the photoresist layer and a chemical reaction is used to remove the portions of the photosensitive layer that were not exposed to light.
- An etch process then cuts through the areas of the Nitinol that are not covered by the photoresist to form the patterned medical sheet. The remaining photoresist is removed to produce the hoops.
- the thin film tube can be used in its plane uniform thickness state, various features may also be formed in the thin film tube including slots, grooves, holes, etc. These features can cut into a solid thin film tube or formed during the thin film tube deposition process. The same machining or etching fabrication processes described above with respect to the hoops can be also be used with the thin film tube. Grooves may be formed in the thin film tube by performing a partial etch or with a mechanical tool that removes some of the thin film tube material.
- the Nitinol tubes used to form the hoops and thin film tube may be formed into the desired fully expanded patterns while in the austenitic phase or in the martensitic phase.
- the phase of the Nitinol material is temperature dependent.
- the austenitic transition temperature A f is between 10° C. to 50° C. about 37° C. and more preferably about 24° C. to about 37° C.
- the Nitinol will be in the Austenitic phase.
- the Nitinol may be fully or partially in the martensitic phase. If the stent hoop pattern is cut in the martensitic phase, it can then be maintained in the expanded shape while it is heat treated to convert the Nitinol to the austenitic phase.
- FIGS. 3-5 show three embodiments of the inventive stent 50 in its compressed state with the hoops 52 ( a )- 52 ( d ) attached to the thin film tube 70 .
- the thin film tube 70 has an inner surface 91 , an outer surface 93 and a longitudinal axis 83 that runs through the center of the tube between the two ends 72 and 74 .
- the diameter 97 of the thin film tube 70 in the expanded state is similar to the diameter of the hoops 52 ( a )- 52 ( d ) in the expanded state.
- FIGS. 3-5 illustrated the stents 50 as having four hoops 52 ( a )- 52 ( d ), however, the actual stent may have many more hoops.
- a longitudinal axis 83 extends through the center of the stent 50 between the ends 72 and 74 .
- the thin film tube 70 keeps the hoops 52 ( a )- 52 ( d ) separated and aligned with the longitudinal axis 83 .
- FIG. 7 when the stent 50 is compressed, small folds 62 are formed in the thin film tube 70 . In the expanded state, the stent diameter expands and the thin film tube 70 is unfolded.
- the inventive thin film tube 70 can trap accumulate plaque and other hazardous build up between the stent and the passageway or duct.
- all of the hoops 52 ( a )- 52 ( d ) are attached to the outer surface 93 of thin film tube 70 .
- the hoops 52 ( a )- 52 ( d ) are uniform in size and may be welded or adhesively bonded to the outer surface of the thin film tube.
- the hoops 52 ( a )- 52 ( d ) are equally spaced apart from each other along the length of the thin film tube 70 .
- the spacing P of the hoops 52 ( a )- 52 ( d ) affects the stiffness of the stent 50 .
- the stent 50 will be stiffer if the hoops 52 ( a )- 52 ( d ) are placed very close to each other on the thin film tube, rather than spaced farther apart.
- a stent is shown with the hoops 52 ( a )- 52 ( d ) attached to the inner surface 91 of the thin film tube 70 .
- the hoops 52 ( a )- 52 ( d ) are concealed from view by the thin film tube 70 .
- the thin film tube 70 is shown as partially covering hoop 52 ( d ) and completely removed from hoops 52 ( a )- 52 ( c ).
- the thin film tube 70 provides a smooth outer surface for the stent 50 and may reduce the friction of the stent 50 as it is deployed or retracted through a tubular delivery device.
- the hoops 52 ( a )- 52 ( d ) are arranged in an alternating pattern along the length of the thin film tube 70 .
- Hoops 52 ( a ) and 52 ( c ) are attached to the outer surface 93 while the adjacent hoops 52 ( b ) and 52 ( d ) are attached to the inner surface 91 of the thin film tube 70 .
- This alternating pattern of hoops 52 coupled to the inner and outer surfaces of the thin tube 70 may continue along the length of the stent 50 .
- the hoops 52 ( a ) and 52 ( c ) attached to the outer surface 93 of the thin film tube 70 may have a larger diameter than the hoops 52 ( b ) and 52 ( d ) which are attached to the inner surface 91 .
- the thin film tube 70 may have a uniform diameter and thickness along the axial length.
- the stent may have an arrangement of hoops that are attached to the inner and outer surfaces of the thin film tube in any pattern.
- the stent may have pattern that includes one or more adjacent hoops mounted on the inner surface thin film tube followed by one or more adjacent hoops mounted on the outer surface.
- the alternating inner and outer surface pattern of hoops may inherently prevent excessive movement of the hoops even if the hoops are not bonded to the thin film tube.
- the stent illustrated in FIG. 5 has a pattern of hoops mounted inside and outside the thin film tube. If the inner diameter of the outer hoops 52 ( a ) and ( c ) is smaller than the outer diameter of the inner hoops 52 ( b ) and ( d ), the adjacent hoops can only slide a limited distance along the thin film tube. When two adjacent hoops move close to each other, the tube is pinched between the outer diameter of one of the hoops and the inner diameter of the adjacent hoop preventing any further movement of the hoops.
- the hoops are preferably attached to the thin film tube in the expanded state. As discussed, the hoops are attached to either the inner surface or the outer surface of the thin film tube. It may be easier to attach the hoops to the outer surface of the expanded thin film tube because the contact areas at the outer surface are more accessible to machinery.
- the thin film tube can be attached to the hoops including: welding, soldering, adhesives, and mechanical coupling.
- the hoops are welded at one or more locations at the junctions between the hoops and the thin film tube. If the hoop is welded to the thin film tube at more than one point, the weld points may be symmetrically spaced around the diameter of the hoop.
- the welds should be on opposite sides on the hoop. If four weld points are used, the welds should be spaced at 90° intervals around the hoop.
- special welding methods may be required. For example, laser welding is used to attach two Nitinol parts.
- CO 2 and ND:YAG laser welding can both be used to weld Nitinol.
- Electron beam welding can also be used to weld smaller parts together in a vacuum processing chamber.
- Other possible welding methods include: friction welding and fusion welding.
- the thin film tube may be deposited directly onto the hoops so that the thin film tube is deposited and bonded to the hoops simultaneously.
- the expanded hoops are placed on a cylindrical mandrel that holds the hoops in alignment.
- the thin film tube is then vapor deposited directly onto the hoops and mandrel.
- the deposited material is fused to the hoops during the deposition process and forms a thin film that covers the gaps between all of the struts and loops of the adjacent hoops. If the mandrel has an outer diameter that is similar to the inner diameter of the hoops, the stent will be similar to the stent illustrated in FIG. 3 .
- the outer diameter of the hoops may be held within a tube and the Nitinol thin film may be deposited on the inner surfaces of the hoops forming a film at the outer diameter of the hoops between the struts and loops.
- This stent is similar to the illustration in FIG. 4 .
- adhesives are used to attach the thin film tube to the hoops.
- the adhesive must be biocompatible with the patient.
- the adhesive may be a thermal set polymer, an epoxy adhesive or any other type of biocompatible adhesive.
- the adhesive may be applied while the hoops and thin film tube are fully expanded to avoid applying the adhesive between adjacent struts and loops.
- the adhesive may be applied to the hoops in the compressed state to help hold the stent in the compressed state during the delivery process.
- mechanical connections may be used to fasten the hoops to the thin film tube.
- the hoops and thin film tube are held together with tabs and slots.
- thin tabs may be formed on the ends of the hoops on the loop sections. During the stent assembly process, the tabs are bent and placed through corresponding slots formed around the diameter of the thin film tube.
- the inventive stent components are held together when the stent is compressed and during the insertion process.
- the connection between the hoops and thin film tube may be less critical.
- the hoops expand and the bonds may be broken.
- the hoop expands radially, it holds the thin film tube against the inner walls of the vessel. In the expanded state there is no need for these components to be bonded together.
- the stent components should not be separated if the thin film tube is mounted to the inner diameter of the hoops.
- various different surface processes can be performed on the hoops and thin film tube.
- surface processing may be performed on the stent or on the hoops and/or thin film tube individually before assembly.
- the hoops and thin film tube may be passivated by exposing the Nitinol to oxygen to form a layer of metal oxide which helps to prevent corrosion.
- the hoops and thin film tube may also be polished to remove any rough surfaces through processes such as: mechanical polishing, electro polishing or chemical mechanical polishing. This polishing removes any sharp surfaces that may have been formed during the cutting processes.
- the hoops and thin film tube may be textured to improve the adhesion of coatings applied to the stent.
- the texturing can be through photochemical etching, sand blasting, tumbling, etc. These textured surfaces can then be coated with different materials that will improve the stent's performance. These chemical coatings are generally intended to improve the biocompatibility of the stent within the patient's body by preventing rejection and resisting infection. These surface coatings include polymers, therapeutic agents and bioactive materials.
- the thin film tube may be used as a drug delivery system.
- the thin film tube may be coated with polymers, therapeutic agents, bioactive materials which are delivered to the damaged vessel when the stent is deployed into the patient. As the stent expands, the coated thin film tube contacts the inner diameter of the vessel, delivering the coated drugs to the target area.
- some of the hoops and thin film tube may also be coated with a radio-opaque material that is detectable with x-rays.
- the radio-opaque materials may alternatively be attached to the Nitinol hoops or thin film tube by laser welding, adhesives, mechanical fasteners, etc.
- the implant area can be x-rayed to determine the exact position of the stent. If the stent is improperly positioned, the error can be detected and corrected.
- the stent is ready for implantation.
- the stent is normally cooled below the martensitic to transform the Nitinol to the martensitic phase before the stent is compressed into a compact state for delivery into a patient.
- the martensitic transformation temperature M f may be between about 0° to 15° C.
- the hoops and thin film tube of the stent can be compressed into a small area.
- the compressed Nitinol alloy will remain in the compressed shape as long as the temperature remains below the austenitic transition temperature. Because the stent must expand after deployment, the austenitic transition temperature A f is lower than the patient's body temperature.
- FIGS. 6 and 7 show a partial cross section of the stent with the thin film tube 70 attached to the outer diameter of the hoops at the struts 60 like the stent shown in FIG. 4 .
- FIG. 6 shows the stent in the expanded state with the planar thin film tube 70 covering the gaps 65 between the adjacent struts 60 in a substantially planar manner.
- FIG. 7 shows the stent in the compressed state with very small gaps 65 between the adjacent struts 60 .
- the diameter of the thin film tube 70 must also be reduced.
- the thin film tube 70 folds axially inward between the adjacent struts 60 .
- the outer diameter of the compressed stent is fairly smooth because any sharp edges formed by the folded thin film 62 are bent inward.
- the thin film may fold outward into the gap between the adjacent struts.
- the thin film tube may be folded away from the gaps between the struts 60 when the stent is compressed.
- the thin film tube may have various surface features such as holes and slots.
- the thin film tube may have grooves that help to create the inward folds between the struts.
- grooves may be formed in the thin film tube along the inner surface close to the edges of the struts and in the outer surface in the middle of the gap between the struts. The thin film tube will tend to bend at the grooves preferably in the manner described with reference to FIG. 7 .
- a crimping tool is used to compress the stent onto the delivery device.
- the crimping tool is designed to push the thin film tube between the adjacent struts as the stent is compressed. After the stent is compressed, the crimping tool is removed and the stent is ready for implantation with the thin film tube folded between the adjacent struts.
- the inventive stent is deployed into a vessel with a delivery apparatus.
- the stent 50 is held in a compressed state within a sheath 40 as the delivery device moves through a patient's blood vessel to a deployment position.
- the sheath 40 is retracted exposing the stent 50 .
- the hoops 52 and thin film 70 expand to the inner diameter of the vessel 95 .
- the stent 50 is fully deployed in this manner and the delivery device is removed from the patient.
- the delivery apparatus can retrieve a partially deployed stent 50 by sliding the sheath 40 back over the exposed stent 50 .
- the sheath 40 causes stent 50 to be recompressed as it is retracted into the delivery device. When the stent is fully retracted, it can be repositioned and redeployed. This capability is useful if the stent 50 is improperly deployed within the vessel 95 .
- the delivery apparatus 1 comprises inner and outer coaxial tubes.
- the inner tube is called the shaft 10 and the outer tube is called the sheath 40 .
- Shaft 10 has proximal and distal ends 12 and 14 respectively.
- the distal end 14 of the shaft terminates at a luer lock hub 5 .
- shaft 10 has a proximal portion 16 which is made from a relatively stiff material such as stainless steel, Nitinol, or any other suitable material, and an distal portion 18 which is made from a polyethylene, polyimide, pellethane, Pebax, Vestamid, Cristamid, Grillamid or any other suitable material known to those of ordinary skill in the art.
- the two portions are joined together by any number of means known to those of ordinary skill in the art.
- the stainless steel proximal end gives the shaft the necessary rigidity or stiffness it needs to effectively push out the stent, while the polymeric distal portion provides the necessary flexibility to navigate tortuous vessels.
- the distal portion 18 of the shaft has a distal tip 20 attached thereto.
- the distal tip 20 has a proximal end 34 whose diameter is substantially the same as the outer diameter of the sheath 40 .
- the distal tip tapers to a smaller diameter from its proximal end to its distal end, wherein the distal end 36 of the distal tip has a diameter smaller than the inner diameter of the sheath.
- a stop 22 which is proximal to the distal tip 20 .
- Stop 22 can be made from any number of materials known in the art, including stainless steel, and is even more preferably made from a highly radiopaque material such as platinum, gold tantalum.
- stop 22 is substantially the same as the inner diameter of sheath 40 , and would actually make frictional contact with the inner surface of the sheath. Stop 22 is releasably coupled to the end of the stent 50 and helps to push the stent 50 out of the sheath during deployment, and helps the stent from migrating proximally into the sheath 40 .
- a stent bed 24 is defined as being that portion of the shaft between the distal tip 20 and the stop 22 .
- the stent bed 24 and the stent 50 are coaxial so that the portion of shaft 18 comprising the stent bed 24 is located within the lumen of the stent 50 .
- the stent bed 24 does not make any contact with stent 50 itself.
- shaft 10 has a guidewire lumen 28 extending along its length from its proximal end 12 and exiting through its distal tip 20 . This allows the shaft 10 to receive a guidewire much in the same way that an ordinary balloon angioplasty catheter receives a guidewire.
- Such guidewires are well known in art and help guide catheters and other medical devices through the vasculature of the body.
- Sheath 40 is preferably a polymeric catheter and has a proximal end 42 terminating at a hub 52 . Sheath 40 also has a distal end 44 which terminates at the proximal end 34 of distal tip 20 of the shaft 18 , when the stent is in its fully un-deployed position.
- the distal end 44 of sheath 40 includes a radiopaque marker band 46 disposed along its outer surface. As will be explained below, the stent is fully deployed when the marker band 46 is lined up with radiopaque stop 22 , thus indicating to the physician that it is now safe to remove the apparatus 1 from the body.
- Sheath 40 preferably comprises an outer polymeric layer and an inner polymeric layer.
- Braided reinforcing layer is preferably made from stainless steel.
- the use of braided reinforcing layers in other types of medical devices can be found in U.S. Pat. No. 3,585,707 issued to Stevens on Jun. 22, 1971, U.S. Pat. No. 5,045,072 issued to Castillo et al. on Sep. 3, 1991, and U.S. Pat. No. 5,254,107 issued to Soltesz on Oct. 19, 1993, all of which are hereby incorporated herein by reference.
- FIGS. 10 and 11 show the stent 50 as being in its fully un-deployed position. This is the position the stent is in when the apparatus 1 is inserted into the vasculature and its distal end is navigated to a target site.
- Stent 50 is disposed around stent bed 24 and at the distal end 44 of sheath 40 .
- the distal tip 20 of the shaft 10 is distal to the distal end 44 of the sheath 40
- the proximal end 12 of the shaft 10 is proximal to the proximal end 42 of the sheath 40 .
- the stent 50 is in a compressed state and makes frictional contact with the inner surface 48 of the sheath 40 .
- sheath 40 and shaft 10 are locked together at their proximal ends by a Touhy Borst valve 8 . This prevents any sliding movement between the shaft and sheath which could result in a premature deployment or partial deployment of the stent.
- the Touhy Borst valve 8 is opened so that that the sheath 40 and shaft 10 are no longer locked together.
- apparatus 1 deploys stent 50 should be readily apparent.
- the apparatus 1 is first inserted into a vessel so that the stent bed 24 is at a target diseased site. Once this has occurred the physician would open the Touhy Borst valve 8 . The physician would then grasp the proximal end 12 of shaft 10 so as to hold it in place. Thereafter, the physician would grasp the proximal end 42 of sheath 40 and slide it proximal, relative to the shaft 40 . Stop 22 prevents the stent 50 from sliding back with the sheath 40 , so that as the sheath 40 is moved back, the stent 50 is pushed out of the distal end 44 of the sheath 40 . Stent deployment is complete when the radiopaque band 46 on the sheath 40 is proximal to radiopaque stop 22 . The apparatus 1 can now be withdrawn through stent 50 and removed from the patient.
- the stop 22 is releasably coupled to the stent 50 . If the stent 50 is properly positioned, the physician actuates a release mechanism and the stop 22 releases the stent 50 into the patient before removing the delivery apparatus 1 . If a partially deployed stent 50 needs to be recovered, the physician would hold the proximal end 12 of shaft 10 in place and slide the proximal end 42 of the sheath 40 to retract the stent 50 back within the sheath 40 . After the stent 50 is fully retracted, the delivery device 1 can be repositioned and the stent 50 can be redeployed as described above.
- delivery device can cut the stent to a desired length when a cutting mechanism is actuated by the physician.
- the hoops of the inventive stent are held together by a thin film tube.
- the delivery device only deploys a portion of the stent. After the desired length of the stent has been deployed into the patient, it can shorten the stent at one of the thin film sections between the adjacent hoops still in the delivery device.
- the delivery device may include one or more small blades that cuts through of the thin film around the diameter between two adjacent hoops. The blades may extend radially and may also rotate within the delivery device to cut the thin film portion of the stent. The blades are located within the sheath and do not come in contact with the patient. After the stent is cut and fully deployed in the patient, the delivery device and the unused portion of the stent are removed from the patient.
- the stent may be broken by pulling two adjacent hoops apart until the thin film tube tears.
- the delivery device has a mechanical device is used to separate the hoops that are adjacent to the section of thin film that is to be torn.
- the thin film material will tear if an applied stress exceeds the ultimate tensile strength of the thin film tube.
- the thin film may be perforated or have a groove that reduces the forces needed to break the thin film of the stent 50 . After the stent 50 is cut or broken, it is fully deployed in the vessel of the patient before the delivery device is removed.
- the balloon expansion stent delivery method may be used for improved placement accuracy.
- the thin film tube is attached to the outer diameter of a series of hoops.
- the tube and hoops are then crimped onto the balloon expansion delivery device.
- the crimped state the smaller diameter, the thin film tube would have a sufficient radial force to constrain the super elastic hoops in the compressed diameter for delivery.
- the crimped stent on the balloon delivery device can be positioned within the patient in-vivo.
- the balloon is inflated to expand the hoops and thin film tube. In its expanded geometry, the thin film tube would not interfere with the superelastic behavior of the stent hoops allowing the stent to perform as intended.
- the described balloon expansion delivery method can be achieved by plastically deforming the thin film tube when fully expanded to the final diameter or by any other means of geometric design.
- the thin film tube In the expanded state, the thin film tube may have thinner and smaller features.
- the thin film tube may be martensitic or austenitic to optimize the strength balance between the stents and the thin film tube.
- the thin film tube in the martensitic phase or possibly the austenitic phase could then be strained during the expansion of the stent to reach the second elastic portion 55 of the Nitinol stress-strain curve.
- the thin film tube material would be deformed to maintain its expanded diameter, yet provide elastic recovery and possibly fatigue resistance for small amounts of alternating strain.
- the geometry of the inventive stent changes significantly from the compressed state to its fully expanded state.
- the strut angle ⁇ and strain levels in the struts and loops are affected.
- all of the struts and loops will strain in a predictable manor so that the stent is structurally reliable and uniform in strength.
- it is preferable to minimize the maximum strain experienced by struts and loops since Nitinol's mechanical strength properties are generally limited by strain rather than by stress like most metal materials. Most metals have a linear relationship between stress and strain in an elastic region and break after the stress exceeds the maximum tensile strength of the metal.
- the specimen deforms elastically until it reaches a particular stress level where the alloy then undergoes a stress-induced phase transformation from the austenite phase to the martensite phase.
- the alloy undergoes significant increases in strain but with little or no corresponding increases in stress.
- the strain increases while the stress remains essentially constant until the transformation of the austenite phase to the martensite phase is complete. Thereafter, further increases in stress are necessary to cause further deformation.
- the martensitic metal first deforms elastically upon the application of additional stress and then plastically with permanent residual deformation.
- the martensitic phase specimen will elastically recover and transform back to the austenite phase.
- the reduction in stress first causes a decrease in strain.
- stress reduction reaches the level at which the martensite phase transforms back into the austenite phase
- the stress level in the specimen will remain essentially constant (but substantially less than the constant stress level at which the austenite transforms to the martensite) until the transformation back to the austenite phase is complete, i.e. there is significant recovery in strain with only negligible corresponding stress reduction.
- the alloys are structurally stronger and more rigid in the austenitic phase than the martensitic phase. After the transformation back to austenite is complete, further stress reduction results in elastic strain reduction.
- shape memory This ability to incur significant strain at relatively constant stress upon the application of a load and to recover from the deformation upon the removal of the load is commonly referred to as super elasticity or “shape memory.” See for example, U.S. Pat. No. 4,665,906 (Jervis) and U.S. Pat. No. 4,925,445 (Sakamoto et al.).
- the transition between martensite and austenite phases can be controlled by the material temperature.
- the shape material is fully martensitic when it is colder than the final martensitic transition temperature M f and fully austenitic when the material is heated above the final austenitic transition temperature A f .
- the alloy may be partially martensitic and partially austenitic at temperatures between the final martensitic transition temperature M f and the final austenitic transition temperature A f . These shape memory alloys are stronger in the full austenitic phase than in the martensitic state, but no longer have the super elastic property. When a shape memory alloy structure is heated, it reverts, or attempts to revert, to its original heat-stable shape.
- the super elastic metal alloys may comprise nickel, titanium and additional elements such as: niobium, hafnium, tantalum, tungsten and gold.
- the ratio of the nickel and titanium in the super elastic alloy will alter the martensite/austenite transition temperatures.
- An alloy having more than 50.5 atomic % nickel has a complete transition temperature Nickel from the martensite phase to the austenite phase (A f ) below human body temperature, so that austenite is the only stable phase at body temperature.
- the alloy preferably has an A f in the range from about 24° C. to about 37° C.
- the M f is about 25° to 50° C. lower than the A f .
- the present invention utilizes a structural geometry that distributes strain to areas of the stent which are less susceptible to failure.
- one of the most vulnerable areas of the stent 50 is the inside surface S of the connecting loops 62 defined by the inner radius which undergoes the most deformation and therefore has the highest level of strain of all the stent features. This area is also critical in that it is usually compressed into the smallest radius on the tissue repair matrix. Stress concentrations are minimized by designing the loops 62 with the largest radii possible and/or have a smaller change in angle ⁇ between the compressed and fully expanded states shown in FIG. 2 .
- Nitinol can withstand extremely large amounts of elastic strain deformation, so the above features are well suited to a stent made from this alloy. This feature allows for maximum utilization of Nitinol or other material capabilities to enhance radial strength, improve stent strength uniformity, improves fatigue life by minimizing local strain levels and improves stent apposition in irregular organ wall shapes and curves.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/608,023 US8142491B2 (en) | 2007-10-24 | 2009-10-29 | Stent segments axially connected by thin film |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/923,308 US8142490B2 (en) | 2007-10-24 | 2007-10-24 | Stent segments axially connected by thin film |
US12/608,023 US8142491B2 (en) | 2007-10-24 | 2009-10-29 | Stent segments axially connected by thin film |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/923,308 Division US8142490B2 (en) | 2007-10-24 | 2007-10-24 | Stent segments axially connected by thin film |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100043199A1 US20100043199A1 (en) | 2010-02-25 |
US8142491B2 true US8142491B2 (en) | 2012-03-27 |
Family
ID=40580423
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/923,308 Expired - Fee Related US8142490B2 (en) | 2007-10-24 | 2007-10-24 | Stent segments axially connected by thin film |
US12/608,023 Expired - Fee Related US8142491B2 (en) | 2007-10-24 | 2009-10-29 | Stent segments axially connected by thin film |
US13/429,986 Active 2028-05-14 US8906085B2 (en) | 2007-10-24 | 2012-03-26 | Stent segments axially connected by thin film |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/923,308 Expired - Fee Related US8142490B2 (en) | 2007-10-24 | 2007-10-24 | Stent segments axially connected by thin film |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/429,986 Active 2028-05-14 US8906085B2 (en) | 2007-10-24 | 2012-03-26 | Stent segments axially connected by thin film |
Country Status (5)
Country | Link |
---|---|
US (3) | US8142490B2 (en) |
EP (1) | EP2224879B1 (en) |
AU (1) | AU2008316617B2 (en) |
CA (1) | CA2703215C (en) |
WO (1) | WO2009055723A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120179241A1 (en) * | 2007-10-24 | 2012-07-12 | Cordis Corporation | Stent segments axially connected by thin film |
US20130204394A1 (en) * | 2007-04-05 | 2013-08-08 | Cordis Corporation | Thin film tissue repair matrix |
US20150033814A1 (en) * | 2013-08-02 | 2015-02-05 | Nano And Advanced Materials Institute Limited | Nanostructured-Lattices Produced by Surface Mechanical Attrition Treatment Method |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461364B1 (en) | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US7842068B2 (en) | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US6391048B1 (en) | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
US9579091B2 (en) | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
DE60144328D1 (en) | 2000-09-08 | 2011-05-12 | Abbott Vascular Inc | Surgical clamp |
US6626918B1 (en) | 2000-10-06 | 2003-09-30 | Medical Technology Group | Apparatus and methods for positioning a vascular sheath |
US6623510B2 (en) | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7905900B2 (en) | 2003-01-30 | 2011-03-15 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US6695867B2 (en) | 2002-02-21 | 2004-02-24 | Integrated Vascular Systems, Inc. | Plunger apparatus and methods for delivering a closure device |
US7211101B2 (en) | 2000-12-07 | 2007-05-01 | Abbott Vascular Devices | Methods for manufacturing a clip and clip |
US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
IES20010547A2 (en) | 2001-06-07 | 2002-12-11 | Christy Cummins | Surgical Staple |
AU2003238642A1 (en) | 2002-06-04 | 2003-12-19 | Christy Cummins | Blood vessel closure clip and delivery device |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
WO2004049982A2 (en) | 2002-12-02 | 2004-06-17 | Gi Dynamics, Inc. | Bariatric sleeve |
US7025791B2 (en) * | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8905937B2 (en) | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
US8821534B2 (en) | 2010-12-06 | 2014-09-02 | Integrated Vascular Systems, Inc. | Clip applier having improved hemostasis and methods of use |
US7857828B2 (en) | 2003-01-30 | 2010-12-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8202293B2 (en) | 2003-01-30 | 2012-06-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
JP4669480B2 (en) | 2003-12-09 | 2011-04-13 | ジーアイ・ダイナミックス・インコーポレーテッド | Intestinal sleeve |
IES20040368A2 (en) | 2004-05-25 | 2005-11-30 | James E Coleman | Surgical stapler |
JP2006064676A (en) * | 2004-08-30 | 2006-03-09 | Tokyo Electron Ltd | Probe needle, method of manufacturing probe needle, and method of manufacturing three dimensional solid structure |
US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
US8313497B2 (en) | 2005-07-01 | 2012-11-20 | Abbott Laboratories | Clip applier and methods of use |
US8808310B2 (en) | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
US9259336B2 (en) * | 2006-06-06 | 2016-02-16 | Cook Medical Technologies Llc | Stent with a crush-resistant zone |
US8556930B2 (en) * | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
US8226681B2 (en) | 2007-06-25 | 2012-07-24 | Abbott Laboratories | Methods, devices, and apparatus for managing access through tissue |
US8795577B2 (en) | 2007-11-30 | 2014-08-05 | Cook Medical Technologies Llc | Needle-to-needle electrospinning |
US20090157101A1 (en) * | 2007-12-17 | 2009-06-18 | Abbott Laboratories | Tissue closure system and methods of use |
US8893947B2 (en) | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
US7841502B2 (en) | 2007-12-18 | 2010-11-30 | Abbott Laboratories | Modular clip applier |
US20090187215A1 (en) * | 2007-12-19 | 2009-07-23 | Abbott Laboratories | Methods and apparatus to reduce a dimension of an implantable device in a smaller state |
US8926688B2 (en) * | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
US9241696B2 (en) | 2008-10-30 | 2016-01-26 | Abbott Vascular Inc. | Closure device |
US8858594B2 (en) | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
US8323312B2 (en) | 2008-12-22 | 2012-12-04 | Abbott Laboratories | Closure device |
US20100179589A1 (en) | 2009-01-09 | 2010-07-15 | Abbott Vascular Inc. | Rapidly eroding anchor |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US20110218568A1 (en) * | 2009-01-09 | 2011-09-08 | Voss Laveille K | Vessel closure devices, systems, and methods |
US9089311B2 (en) | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US9173644B2 (en) * | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US20100185234A1 (en) | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
WO2010102254A2 (en) * | 2009-03-06 | 2010-09-10 | The Regents Of The University Of California | Thin film vascular stent and biocompatible surface treatment |
US20110054492A1 (en) | 2009-08-26 | 2011-03-03 | Abbott Laboratories | Medical device for repairing a fistula |
US8637109B2 (en) * | 2009-12-03 | 2014-01-28 | Cook Medical Technologies Llc | Manufacturing methods for covering endoluminal prostheses |
US8303624B2 (en) | 2010-03-15 | 2012-11-06 | Abbott Cardiovascular Systems, Inc. | Bioabsorbable plug |
US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
SG11201401358VA (en) | 2011-10-10 | 2014-05-29 | Univ Singapore | Membrane for covering a peripheral surface of a stent |
US9175427B2 (en) | 2011-11-14 | 2015-11-03 | Cook Medical Technologies Llc | Electrospun patterned stent graft covering |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
US10315012B2 (en) | 2013-05-06 | 2019-06-11 | Fort Wayne Metals Research Products Corp | Titanium-niobium-hafnium alloy shape memory wire |
CN104939947A (en) * | 2014-03-26 | 2015-09-30 | 上海市第六人民医院 | Brain covered stent with endothelial progenitor cell capture function |
CN106937895B (en) * | 2016-01-05 | 2020-12-18 | 上海微创医疗器械(集团)有限公司 | Covered stent and preparation method thereof |
WO2018111758A1 (en) * | 2016-12-12 | 2018-06-21 | Boston Scientific Scimed, Inc. | Stent trimming devices |
CN106963515B (en) * | 2017-02-24 | 2018-12-18 | 上海长海医院 | A kind of aorta tectorial membrane stent |
CN107126299A (en) * | 2017-06-08 | 2017-09-05 | 有研医疗器械(北京)有限公司 | A kind of high submissive type thoracic aorta covered bracket and its shaper and method |
CN111388144B (en) * | 2020-04-17 | 2022-11-15 | 宿州青智网络科技有限公司 | Easy-to-recycle intravascular stent |
CN111388143B (en) * | 2020-04-17 | 2022-12-20 | 江西神你医疗器械有限公司 | Intravascular stent with elastic energy storage section consisting of Z-shaped rings |
CN214712944U (en) * | 2020-09-30 | 2021-11-16 | 普利瑞医疗科技(苏州)有限公司 | Sectional type medical drug stent |
CN115363819B (en) * | 2022-10-27 | 2023-01-31 | 北京华脉泰科医疗器械股份有限公司 | Covered stent and preparation method thereof |
Citations (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3585707A (en) | 1966-04-13 | 1971-06-22 | Cordis Corp | Method of making tubular products |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4925445A (en) | 1983-09-16 | 1990-05-15 | Fuji Terumo Co., Ltd. | Guide wire for catheter |
US5045072A (en) | 1989-06-13 | 1991-09-03 | Cordis Corporation | Catheter having highly radiopaque, flexible tip |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5254107A (en) | 1991-03-06 | 1993-10-19 | Cordis Corporation | Catheter having extended braid reinforced transitional tip |
US5607464A (en) | 1991-02-28 | 1997-03-04 | Medtronic, Inc. | Prosthetic vascular graft with a pleated structure |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5634941A (en) | 1992-08-18 | 1997-06-03 | Ultrasonic Sensing And Monitoring Systems, Inc. | Vascular graft bypass apparatus |
US5824049A (en) * | 1995-06-07 | 1998-10-20 | Med Institute, Inc. | Coated implantable medical device |
US5922019A (en) | 1995-11-27 | 1999-07-13 | Schneider (Europe) A.G. | Conical stent |
US6071307A (en) | 1998-09-30 | 2000-06-06 | Baxter International Inc. | Endoluminal grafts having continuously curvilinear wireforms |
US6099558A (en) | 1995-10-10 | 2000-08-08 | Edwards Lifesciences Corp. | Intraluminal grafting of a bifuricated artery |
US6139573A (en) | 1997-03-05 | 2000-10-31 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US6174329B1 (en) * | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US6197013B1 (en) * | 1996-11-06 | 2001-03-06 | Setagon, Inc. | Method and apparatus for drug and gene delivery |
US6261320B1 (en) * | 1996-11-21 | 2001-07-17 | Radiance Medical Systems, Inc. | Radioactive vascular liner |
US6287335B1 (en) * | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
US6315794B1 (en) * | 1997-11-13 | 2001-11-13 | Medinol Ltd. | Multilayered metal stent |
US6371982B2 (en) | 1997-10-09 | 2002-04-16 | St. Jude Medical Cardiovascular Group, Inc. | Graft structures with compliance gradients |
US20020051730A1 (en) * | 2000-09-29 | 2002-05-02 | Stanko Bodnar | Coated medical devices and sterilization thereof |
US20020082676A1 (en) * | 2000-12-26 | 2002-06-27 | Chuanting You | Monolayer modification to gold coated stents to reduce adsorption of protein |
US20020133183A1 (en) * | 2000-09-29 | 2002-09-19 | Lentz David Christian | Coated medical devices |
US6475234B1 (en) * | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
US20030018381A1 (en) * | 2000-01-25 | 2003-01-23 | Scimed Life Systems, Inc. | Manufacturing medical devices by vapor deposition |
US20030104028A1 (en) * | 2001-11-29 | 2003-06-05 | Hossainy Syed F.A. | Rate limiting barriers for implantable devices and methods for fabrication thereof |
US20030163017A1 (en) * | 1998-02-19 | 2003-08-28 | Tam Lisa A. | Multi layer radiation delivery balloon |
US6626938B1 (en) | 2000-11-16 | 2003-09-30 | Cordis Corporation | Stent graft having a pleated graft member |
US6638301B1 (en) * | 2002-10-02 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device with radiopacity |
US6699277B1 (en) | 2000-03-09 | 2004-03-02 | Diseno Y Desarrollo Medica, S.A. De C.V. | Stent with cover connectors |
US20040098094A1 (en) | 2002-09-26 | 2004-05-20 | Boyle Christopher T. | Implantable graft and methods of making same |
US6770086B1 (en) | 2000-11-02 | 2004-08-03 | Scimed Life Systems, Inc. | Stent covering formed of porous polytetraflouroethylene |
US20040249445A1 (en) * | 2002-01-31 | 2004-12-09 | Rosenthal Arthur L. | Medical device for delivering biologically active material |
US6865810B2 (en) * | 2002-06-27 | 2005-03-15 | Scimed Life Systems, Inc. | Methods of making medical devices |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US20050106212A1 (en) * | 2001-09-19 | 2005-05-19 | Gertner Michael E. | Metallic structures incorporating bioactive materials and methods for creating the same |
US20050113903A1 (en) * | 2002-01-31 | 2005-05-26 | Scimed Life Systems, Inc. | Medical device for delivering biologically active material |
US20050137677A1 (en) * | 2003-12-17 | 2005-06-23 | Rush Scott L. | Endovascular graft with differentiable porosity along its length |
US6911040B2 (en) * | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
US6936066B2 (en) | 1999-11-19 | 2005-08-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Complaint implantable medical devices and methods of making same |
US6939376B2 (en) * | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20050233062A1 (en) * | 1999-09-03 | 2005-10-20 | Hossainy Syed F | Thermal treatment of an implantable medical device |
US20050267566A1 (en) * | 2003-03-26 | 2005-12-01 | Robert Rioux | Longitudinally expanding medical device |
WO2006034114A2 (en) | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Thin film devices for occlusion of a vessel |
WO2006034301A1 (en) | 2004-09-20 | 2006-03-30 | Cordis Corporation | Thin film medical device and delivery system |
US20060149365A1 (en) * | 2002-10-22 | 2006-07-06 | Medtronic Vascular, Inc. | Stent with eccentric coating |
US7077859B2 (en) * | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
US20060224234A1 (en) * | 2001-08-29 | 2006-10-05 | Swaminathan Jayaraman | Drug eluting structurally variable stent |
US20060229711A1 (en) * | 2005-04-05 | 2006-10-12 | Elixir Medical Corporation | Degradable implantable medical devices |
US20060259131A1 (en) * | 2005-05-16 | 2006-11-16 | Masoud Molaei | Medical devices including metallic films and methods for making same |
US20060259126A1 (en) * | 2005-05-05 | 2006-11-16 | Jason Lenz | Medical devices and methods of making the same |
US20060265052A1 (en) | 2001-03-29 | 2006-11-23 | Isis Innovation Limited | Deployable stent |
US20060276884A1 (en) * | 2002-11-13 | 2006-12-07 | Whye-Kei Lye | Nanoporous stents with magnesium leaching |
WO2007022495A1 (en) | 2005-08-18 | 2007-02-22 | William A. Cook Australia Pty. Ltd. | Design and assembly of fenestrated stent grafts |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US20070077347A1 (en) * | 1996-12-26 | 2007-04-05 | Jacob Richter | Flat process of drug coating for stents |
US20070123977A1 (en) * | 2000-03-15 | 2007-05-31 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US7226474B2 (en) | 2000-05-01 | 2007-06-05 | Endovascular Technologies, Inc. | Modular graft component junctions |
US7261735B2 (en) * | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US20070207186A1 (en) * | 2006-03-04 | 2007-09-06 | Scanlon John J | Tear and abrasion resistant expanded material and reinforcement |
US20070219642A1 (en) * | 1998-12-03 | 2007-09-20 | Jacob Richter | Hybrid stent having a fiber or wire backbone |
US7291165B2 (en) * | 2002-01-31 | 2007-11-06 | Boston Scientific Scimed, Inc. | Medical device for delivering biologically active material |
US7294147B2 (en) | 2002-08-23 | 2007-11-13 | Cook Incorporated | Composite prosthesis |
US20070276470A1 (en) | 2006-05-26 | 2007-11-29 | Dirk Tenne | Occlusion device combination of stent and mesh having offset parallelogram porosity |
US7309349B2 (en) * | 2003-01-23 | 2007-12-18 | Cordis Corporation | Friction reducing lubricant for stent loading and stent delivery systems |
US20080071348A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical Devices |
US7396538B2 (en) * | 2002-09-26 | 2008-07-08 | Endovascular Devices, Inc. | Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
US20080294246A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic Morphology |
US7806924B2 (en) * | 2004-02-18 | 2010-10-05 | Cordis Corporation | Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis |
US7811300B2 (en) * | 2004-09-17 | 2010-10-12 | Codman & Shurtleff, Inc. | Thin film devices for temporary or permanent occlusion of a vessel |
US7837726B2 (en) * | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5104399A (en) * | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5476506A (en) * | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US5824044A (en) * | 1994-05-12 | 1998-10-20 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system |
US5522881A (en) * | 1994-06-28 | 1996-06-04 | Meadox Medicals, Inc. | Implantable tubular prosthesis having integral cuffs |
US5755770A (en) * | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
US6016848A (en) * | 1996-07-16 | 2000-01-25 | W. L. Gore & Associates, Inc. | Fluoropolymer tubes and methods of making same |
US6090128A (en) * | 1997-02-20 | 2000-07-18 | Endologix, Inc. | Bifurcated vascular graft deployment device |
US5980565A (en) * | 1997-10-20 | 1999-11-09 | Iowa-India Investments Company Limited | Sandwich stent |
US6352554B2 (en) * | 1998-05-08 | 2002-03-05 | Sulzer Vascutek Limited | Prosthetic tubular aortic conduit and method for manufacturing the same |
EP1726271B1 (en) * | 1998-09-30 | 2012-07-25 | Bard Peripheral Vascular, Inc. | Selective adherence of stentgraft coverings, mandrel and method of making stent-graft device |
US6334868B1 (en) * | 1999-10-08 | 2002-01-01 | Advanced Cardiovascular Systems, Inc. | Stent cover |
US6773456B1 (en) * | 2001-03-23 | 2004-08-10 | Endovascular Technologies, Inc. | Adjustable customized endovascular graft |
US7288111B1 (en) * | 2002-03-26 | 2007-10-30 | Thoratec Corporation | Flexible stent and method of making the same |
AU2003258337A1 (en) * | 2002-08-23 | 2004-03-11 | Cook Incorporated | Asymmetric stent graft attachment |
US20050090888A1 (en) * | 2003-10-28 | 2005-04-28 | Hines Richard A. | Pleated stent assembly |
US7575591B2 (en) * | 2003-12-01 | 2009-08-18 | Cordis Corporation | Prosthesis graft with Z pleating |
CA2557657C (en) * | 2004-02-27 | 2013-06-18 | Aortx, Inc. | Prosthetic heart valve delivery systems and methods |
US7887579B2 (en) * | 2004-09-29 | 2011-02-15 | Merit Medical Systems, Inc. | Active stent |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US8568468B2 (en) * | 2007-12-06 | 2013-10-29 | Cook Medical Technologies Llc | Stent-graft comprising at least one reinforced hole |
-
2007
- 2007-10-24 US US11/923,308 patent/US8142490B2/en not_active Expired - Fee Related
-
2008
- 2008-10-24 EP EP08841583.1A patent/EP2224879B1/en not_active Not-in-force
- 2008-10-24 WO PCT/US2008/081192 patent/WO2009055723A2/en active Application Filing
- 2008-10-24 CA CA2703215A patent/CA2703215C/en not_active Expired - Fee Related
- 2008-10-24 AU AU2008316617A patent/AU2008316617B2/en not_active Ceased
-
2009
- 2009-10-29 US US12/608,023 patent/US8142491B2/en not_active Expired - Fee Related
-
2012
- 2012-03-26 US US13/429,986 patent/US8906085B2/en active Active
Patent Citations (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3585707A (en) | 1966-04-13 | 1971-06-22 | Cordis Corp | Method of making tubular products |
US4925445A (en) | 1983-09-16 | 1990-05-15 | Fuji Terumo Co., Ltd. | Guide wire for catheter |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US5045072A (en) | 1989-06-13 | 1991-09-03 | Cordis Corporation | Catheter having highly radiopaque, flexible tip |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5607464A (en) | 1991-02-28 | 1997-03-04 | Medtronic, Inc. | Prosthetic vascular graft with a pleated structure |
US5653745A (en) | 1991-02-28 | 1997-08-05 | Medtronic, Inc. | Prosthetic vascular graft with a pleated structure |
US5254107A (en) | 1991-03-06 | 1993-10-19 | Cordis Corporation | Catheter having extended braid reinforced transitional tip |
US5634941A (en) | 1992-08-18 | 1997-06-03 | Ultrasonic Sensing And Monitoring Systems, Inc. | Vascular graft bypass apparatus |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5824049A (en) * | 1995-06-07 | 1998-10-20 | Med Institute, Inc. | Coated implantable medical device |
US6099558A (en) | 1995-10-10 | 2000-08-08 | Edwards Lifesciences Corp. | Intraluminal grafting of a bifuricated artery |
US5922019A (en) | 1995-11-27 | 1999-07-13 | Schneider (Europe) A.G. | Conical stent |
US6533810B2 (en) | 1995-11-27 | 2003-03-18 | Schneider (Europe) Ag | Conical stent |
US6174329B1 (en) * | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US6197013B1 (en) * | 1996-11-06 | 2001-03-06 | Setagon, Inc. | Method and apparatus for drug and gene delivery |
US6261320B1 (en) * | 1996-11-21 | 2001-07-17 | Radiance Medical Systems, Inc. | Radioactive vascular liner |
US20070077347A1 (en) * | 1996-12-26 | 2007-04-05 | Jacob Richter | Flat process of drug coating for stents |
US6139573A (en) | 1997-03-05 | 2000-10-31 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US6371982B2 (en) | 1997-10-09 | 2002-04-16 | St. Jude Medical Cardiovascular Group, Inc. | Graft structures with compliance gradients |
US6315794B1 (en) * | 1997-11-13 | 2001-11-13 | Medinol Ltd. | Multilayered metal stent |
US20030163017A1 (en) * | 1998-02-19 | 2003-08-28 | Tam Lisa A. | Multi layer radiation delivery balloon |
US6071307A (en) | 1998-09-30 | 2000-06-06 | Baxter International Inc. | Endoluminal grafts having continuously curvilinear wireforms |
US6475234B1 (en) * | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
US6887265B2 (en) * | 1998-10-26 | 2005-05-03 | Medinol Ltd. | Balloon expandable covered stents |
US20070219642A1 (en) * | 1998-12-03 | 2007-09-20 | Jacob Richter | Hybrid stent having a fiber or wire backbone |
US6287335B1 (en) * | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
US7807211B2 (en) * | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US20110001271A1 (en) * | 1999-09-03 | 2011-01-06 | Advanced Cardiovascular Systems, Inc. | Thermal Treatment Of An Implantable Medical Device |
US20110008529A1 (en) * | 1999-09-03 | 2011-01-13 | Advanced Cardiovascular Systems, Inc. | Thermal Treatment Of An Implantable Medical Device |
US20050233062A1 (en) * | 1999-09-03 | 2005-10-20 | Hossainy Syed F | Thermal treatment of an implantable medical device |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6936066B2 (en) | 1999-11-19 | 2005-08-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Complaint implantable medical devices and methods of making same |
US20030018381A1 (en) * | 2000-01-25 | 2003-01-23 | Scimed Life Systems, Inc. | Manufacturing medical devices by vapor deposition |
US6938668B2 (en) * | 2000-01-25 | 2005-09-06 | Scimed Life Systems, Inc. | Manufacturing medical devices by vapor deposition |
US6699277B1 (en) | 2000-03-09 | 2004-03-02 | Diseno Y Desarrollo Medica, S.A. De C.V. | Stent with cover connectors |
US20070123977A1 (en) * | 2000-03-15 | 2007-05-31 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US7226474B2 (en) | 2000-05-01 | 2007-06-05 | Endovascular Technologies, Inc. | Modular graft component junctions |
US20020051730A1 (en) * | 2000-09-29 | 2002-05-02 | Stanko Bodnar | Coated medical devices and sterilization thereof |
US20020133183A1 (en) * | 2000-09-29 | 2002-09-19 | Lentz David Christian | Coated medical devices |
US6770086B1 (en) | 2000-11-02 | 2004-08-03 | Scimed Life Systems, Inc. | Stent covering formed of porous polytetraflouroethylene |
US6626938B1 (en) | 2000-11-16 | 2003-09-30 | Cordis Corporation | Stent graft having a pleated graft member |
US7077859B2 (en) * | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
US20020082676A1 (en) * | 2000-12-26 | 2002-06-27 | Chuanting You | Monolayer modification to gold coated stents to reduce adsorption of protein |
US20060265052A1 (en) | 2001-03-29 | 2006-11-23 | Isis Innovation Limited | Deployable stent |
US7261735B2 (en) * | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US20060224234A1 (en) * | 2001-08-29 | 2006-10-05 | Swaminathan Jayaraman | Drug eluting structurally variable stent |
US20050106212A1 (en) * | 2001-09-19 | 2005-05-19 | Gertner Michael E. | Metallic structures incorporating bioactive materials and methods for creating the same |
US6939376B2 (en) * | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20030104028A1 (en) * | 2001-11-29 | 2003-06-05 | Hossainy Syed F.A. | Rate limiting barriers for implantable devices and methods for fabrication thereof |
US6911040B2 (en) * | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
US20040249445A1 (en) * | 2002-01-31 | 2004-12-09 | Rosenthal Arthur L. | Medical device for delivering biologically active material |
US7291165B2 (en) * | 2002-01-31 | 2007-11-06 | Boston Scientific Scimed, Inc. | Medical device for delivering biologically active material |
US20050113903A1 (en) * | 2002-01-31 | 2005-05-26 | Scimed Life Systems, Inc. | Medical device for delivering biologically active material |
US6865810B2 (en) * | 2002-06-27 | 2005-03-15 | Scimed Life Systems, Inc. | Methods of making medical devices |
US7294147B2 (en) | 2002-08-23 | 2007-11-13 | Cook Incorporated | Composite prosthesis |
US20040098094A1 (en) | 2002-09-26 | 2004-05-20 | Boyle Christopher T. | Implantable graft and methods of making same |
US7396538B2 (en) * | 2002-09-26 | 2008-07-08 | Endovascular Devices, Inc. | Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
US6638301B1 (en) * | 2002-10-02 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device with radiopacity |
US20060149365A1 (en) * | 2002-10-22 | 2006-07-06 | Medtronic Vascular, Inc. | Stent with eccentric coating |
US20060276885A1 (en) * | 2002-11-13 | 2006-12-07 | Whye-Kei Lye | Nanoporous stents with improved radiolucency |
US20060276884A1 (en) * | 2002-11-13 | 2006-12-07 | Whye-Kei Lye | Nanoporous stents with magnesium leaching |
US7713573B2 (en) * | 2002-11-13 | 2010-05-11 | Medtronic Vascular, Inc. | Method for loading nanoporous layers with therapeutic agent |
US7309349B2 (en) * | 2003-01-23 | 2007-12-18 | Cordis Corporation | Friction reducing lubricant for stent loading and stent delivery systems |
US20050267566A1 (en) * | 2003-03-26 | 2005-12-01 | Robert Rioux | Longitudinally expanding medical device |
US20050137677A1 (en) * | 2003-12-17 | 2005-06-23 | Rush Scott L. | Endovascular graft with differentiable porosity along its length |
US7806924B2 (en) * | 2004-02-18 | 2010-10-05 | Cordis Corporation | Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis |
US7811300B2 (en) * | 2004-09-17 | 2010-10-12 | Codman & Shurtleff, Inc. | Thin film devices for temporary or permanent occlusion of a vessel |
WO2006034114A2 (en) | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Thin film devices for occlusion of a vessel |
WO2006034301A1 (en) | 2004-09-20 | 2006-03-30 | Cordis Corporation | Thin film medical device and delivery system |
US7837726B2 (en) * | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
US20060229711A1 (en) * | 2005-04-05 | 2006-10-12 | Elixir Medical Corporation | Degradable implantable medical devices |
US20060259126A1 (en) * | 2005-05-05 | 2006-11-16 | Jason Lenz | Medical devices and methods of making the same |
US20060259131A1 (en) * | 2005-05-16 | 2006-11-16 | Masoud Molaei | Medical devices including metallic films and methods for making same |
US7854760B2 (en) * | 2005-05-16 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
WO2007022495A1 (en) | 2005-08-18 | 2007-02-22 | William A. Cook Australia Pty. Ltd. | Design and assembly of fenestrated stent grafts |
US20070207186A1 (en) * | 2006-03-04 | 2007-09-06 | Scanlon John J | Tear and abrasion resistant expanded material and reinforcement |
US20070276470A1 (en) | 2006-05-26 | 2007-11-29 | Dirk Tenne | Occlusion device combination of stent and mesh having offset parallelogram porosity |
US20080071348A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical Devices |
US20080294246A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic Morphology |
Non-Patent Citations (2)
Title |
---|
International Search Report dated Jul. 12, 2010 corresponding to PCT/US2008/081192. |
Office Action mailed Mar. 11, 2011 in related U.S. Appl. No. 11/923,308. |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130204394A1 (en) * | 2007-04-05 | 2013-08-08 | Cordis Corporation | Thin film tissue repair matrix |
US20120179241A1 (en) * | 2007-10-24 | 2012-07-12 | Cordis Corporation | Stent segments axially connected by thin film |
US8906085B2 (en) * | 2007-10-24 | 2014-12-09 | Cordis Corporation | Stent segments axially connected by thin film |
US20150033814A1 (en) * | 2013-08-02 | 2015-02-05 | Nano And Advanced Materials Institute Limited | Nanostructured-Lattices Produced by Surface Mechanical Attrition Treatment Method |
US9517545B2 (en) * | 2013-08-02 | 2016-12-13 | Nano And Advanced Materials Institute Limited | Nanostructured-lattices produced by surface mechanical attrition treatment method |
Also Published As
Publication number | Publication date |
---|---|
EP2224879A2 (en) | 2010-09-08 |
US20120179241A1 (en) | 2012-07-12 |
US8142490B2 (en) | 2012-03-27 |
CA2703215A1 (en) | 2009-04-30 |
US20100043199A1 (en) | 2010-02-25 |
EP2224879B1 (en) | 2017-04-26 |
WO2009055723A3 (en) | 2010-08-26 |
WO2009055723A2 (en) | 2009-04-30 |
AU2008316617A1 (en) | 2009-04-30 |
US8906085B2 (en) | 2014-12-09 |
US20090112306A1 (en) | 2009-04-30 |
AU2008316617B2 (en) | 2013-12-19 |
CA2703215C (en) | 2016-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8142491B2 (en) | Stent segments axially connected by thin film | |
US6375676B1 (en) | Self-expanding stent with enhanced delivery precision and stent delivery system | |
US6605110B2 (en) | Stent with enhanced bendability and flexibility | |
EP1667605B1 (en) | Radiopaque markers for medical devices | |
EP0951877B1 (en) | A multi-laminate stent having superelastic articulated sections | |
EP1212991B1 (en) | An intravascular device with improved radiopacity | |
EP1251796B1 (en) | Self-expanding stent with enhanced delivery precision | |
US20010025130A1 (en) | Method for making a multi-laminate stent having superelastic articulated sections | |
AU2013205219B2 (en) | Stent segments axially connected by thin film | |
EP1464303A2 (en) | Self-expanding stent with enhanced delivery precision and stent delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ZAAA | Notice of allowance and fees due |
Free format text: ORIGINAL CODE: NOA |
|
ZAAB | Notice of allowance mailed |
Free format text: ORIGINAL CODE: MN/=. |
|
AS | Assignment |
Owner name: ADVANCED BIO PROSTHETIC SURFACES, LTD., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;REEL/FRAME:027719/0824 Effective date: 20120126 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: SPI DALLAS INVESTMENTS, LP, TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036384/0818 Effective date: 20150722 |
|
AS | Assignment |
Owner name: SPI DALLAS INVESTMENTS, LP, TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036434/0813 Effective date: 20150722 Owner name: LENNOX CAPITAL PARTNERS, LP, TEXAS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036384 FRAME: 0818. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036465/0091 Effective date: 20150722 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: PALMAZ, JULIO, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037820/0400 Effective date: 20150917 |
|
AS | Assignment |
Owner name: OAK COURT PARTNERS, LTD., NEVADA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037827/0568 Effective date: 20150917 Owner name: OAK COURT PARTNERS, LTD., NEVADA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037836/0646 Effective date: 20150917 |
|
AS | Assignment |
Owner name: OAK COURT PARTNERS, LTD., TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037839/0278 Effective date: 20151230 |
|
AS | Assignment |
Owner name: VACTRONIX SCIENTIFIC, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ADVANCED BIO PROSTHETIC SURFACES, LTD.;REEL/FRAME:042117/0331 Effective date: 20160805 |
|
AS | Assignment |
Owner name: VACTRONIX SCIENTIFIC, LLC, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VACTRONIX SCIENTIFIC, INC.;REEL/FRAME:045846/0917 Effective date: 20180516 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20240327 |